ALMIRALL, S.A. «...678910...» Página 7 de 48 desde 01/07/1988 hasta 29/05/2024 21/09/2018 07:53 ALMIRALL, S.A. Transmissions and purchases of capital undertakings Almirall closes agreement with Allergan and acquires its US medical dermatology portfolio Número de registro: 269787 Relacionado con 268848 del 03/08/2018 (07:59) 18/09/2018 08:02 ALMIRALL, S.A. R&D: new licenses, patents and registered trademarks European Commission (EC) approves Almirall’s ILUMETRI® for moderate-to-severe chronic plaque Psoriasis Número de registro: 269681 03/08/2018 08:37 ALMIRALL, S.A. Transmissions and purchases of capital undertakings Presentación a inversores: Almirall adquiere el portfolio de dermatología médica en EE.UU de Allergan Número de registro: 268856 03/08/2018 07:59 ALMIRALL, S.A. Transmissions and purchases of capital undertakings Almirall to acquire US medical dermatology portfolio from Allergan Número de registro: 268848 Relacionado con 269787 del 21/09/2018 (07:53) 30/07/2018 07:52 ALMIRALL, S.A. Interim financial information La sociedad remite información sobre los resultados del primer semestre de 2018 Número de registro: 268607 30/07/2018 07:42 ALMIRALL, S.A. Information on P&L. - Announcements of public presentations and meetings Almirall announces that a webcast with analysts and institutional investors will be held today at 10.00 am CET related to the H1 2018 Financial Results. Please find attached the presentation for the Webcast and the Press Release Número de registro: 268603 27/07/2018 14:21 ALMIRALL, S.A. R&D: new licenses, patents and registered trademarks Almirall receives positive CHMP opinion for tildrakizumab for the treatment of patients with moderate-to-severe chronic plaque psoriasis Número de registro: 268568 26/07/2018 13:00 ALMIRALL, S.A. R&D: new licenses, patents and registered trademarks Almirall announces that both phase III trials of KX2-391 for actinic keratosis achieved primary endpoint Número de registro: 268397 25/06/2018 08:04 ALMIRALL, S.A. Others on business performance and financial information Almirall’s R&D Pipeline Update Número de registro: 267110 14/06/2018 18:01 ALMIRALL, S.A. Increases and decreases of share capital Almirall comunica que hoy, 14 de junio de 2018 han sido admitidas a cotización las 902.547 acciones nuevas, procedentes del dividendo flexible, en las Bolsas de Valores de Madrid, Barcelona, Bilbao y Valencia Número de registro: 266818 Página 7 de 48 «...678910...»